NCT01881763View on ClinicalTrials.gov

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2017

Study Completion Date

July 31, 2017

Conditions

Unipolar DepressionBipolar Depression

Interventions

DRUG

Ketamine

Ketamine 1-2 mgr/ kg IV

DRUG

Methohexital

Methohexital 0.5-1mg/kg IV

Trial Locations (1)

11004

Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Northwell Health

OTHER